Lung Ultrasound for the Cardiologist
Complexity Of Chronic Thromboembolic Pulmonary Hypertension
A detailed overview of the complex nature of chronic thromboembolic pulmonary hypertension and associated comorbidity.
Transcript
Charles D. Burger, MD: Group 4 chronic thromboembolic PH [pulmonary hypertension], or CTEPH, is a very challenging area because it's difficult to understand exactly why a patient goes on to develop chronic thromboembolic pulmonary hypertension. Experience would suggest that the patient probably had a blood clot in the venous circulation in the legs that dislodged and ended up in the pulmonary circulation, what's referred to as a pulmonary embolus. If that's diagnosed and treated with blood thinners, 99% of the time or more, the clot in the leg and the clot in the lung completely resolve without any long-term injury to the pulmonary circulation. About 1% of the time, maybe less, that does not happen and the clot in the lung is replaced with a cellular material that adheres to the lining of the inside of the pulmonary arteries, blocks blood flow, and narrows the blood vessels.
That's referred to as chronic thromboembolism and can be detected with imaging studies. Those patients, because of the blood vessel narrowing, have a high resistance to blood flow. The heart has to generate a higher pressure to overcome that resistance. That is pulmonary hypertension, and it's in association with chronic thromboembolism, hence the name chronic thromboembolic pulmonary hypertension.
As you work backward from the diagnosis through the patient's history, there have been efforts to identify patients who might be at more risk for chronic thromboembolic pulmonary hypertension. If they had a large pulmonary embolus and there was an effect on the heart from that large pulmonary embolus at the time of the acute event, that patient might be at higher risk. But the overwhelming majority of those patients have full recovery using only blood thinners.
There may be patients who have blood clots and never know it. Why might that occur? If you're sedentary for a long period of time—a long car ride or a long plane ride, for example—the circulation in the legs is also sedentary. You might develop a clot in the legs and never really know it. Maybe there was a little swelling, you got up and about later, and you were fine; or a tiny clot broke off and went to the lung, but it wasn't very symptomatic. There could be patients who have what we call subclinical venous thromboembolism who go on to develop chronic thromboembolic disease.
Why would I even raise that as a possibility? Because 25% to 45% of patients don't have a previous diagnosis of a venous clot in the legs or pulmonary embolus. Obviously, if the initial cause of CTEPH was a blood clot and the patient never knew it, it was asymptomatic or subclinical. Therefore, you can be surprised at times that patients without this history have CTEPH. That's why it's very important to emphasize that all patients who are diagnosed with pulmonary hypertension receive a screening test for CTEPH. The screening test that's recommended based on the guidelines is a ventilation/perfusion lung scan, a VQ scan. If that's positive, then you need to perform additional testing because those patients may have a chance for a curative surgery—a pulmonary thromboendarterectomy—or be eligible for specific therapy with riociguat. It's a very important subgroup to identify.
If all of this overwhelms you as a provider, you need to refer the patient to a pulmonary hypertension center where they have expertise. We have a multidisciplinary group that includes pulmonology, cardiology, critical care doctors, special radiologists who look at these types of imaging studies, and cardiothoracic surgery, etc. We review all these cases to determine the diagnosis and the best treatment. It is very important to have that expertise because it can be very subtle. It's very important to make a correct diagnosis in order to make the correct treatment recommendations.
Hilary M. DuBrock, MD: There are various comorbidities and risk factors for chronic thromboembolic pulmonary hypertension. These include chronic inflammatory disorders; chronic infections, such as infected pacemaker leads; and patients who have ventricular atrial shunts, a prior splenectomy, or antiphospholipid antibody syndrome or lupus anticoagulant. Additionally, malignancy is a risk factor for chronic thromboembolic pulmonary hypertension and is an important comorbidity in patients with CTEPH. Compared to idiopathic pulmonary arterial hypertension, patients with CTEPH tend to have more comorbidities, and this can impact perioperative risk stratification and eligibility for procedures such as pulmonary thromboendarterectomy.
NewsletterStay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Evaluation Of Patients With Chronic Thromboembolic Pulmonary ...
Our systems have detected unusual traffic activity from your network. Please complete this reCAPTCHA to demonstrate that it's you making the requests and not a robot. If you are having trouble seeing or completing this challenge, this page may help. If you continue to experience issues, you can contact JSTOR support.
Block Reference: #19fd0180-7f16-11f0-994c-a305ee321708VID: #IP: 167.71.87.121Date and time: Fri, 22 Aug 2025 05:08:55 GMT
Javascript is disabled
Go back to JSTOR
©2000- ITHAKA. All Rights Reserved. JSTOR®, the JSTOR logo, JPASS®, and ITHAKA® are registered trademarks of ITHAKA.
Here's Everything About Chronic Thromboembolic Pulmonary Hypertension
Do you feel fatigued? Have you stopped venturing out owing to the swelling of your legs? Do you find difficult to breathe? Then, it is the right time to consult your doctor as this can put you at the risk of Chronic Thromboembolic Pulmonary Hypertension (CTEPH). This rare condition may rob your peace by giving you a tough time. If you are not aware of this deadly condition then here we tell you about the symptoms and risk factors which you shouldn't miss. Also, opt for timely treatment and improve your quality of life.
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) can be dangerous for you. It is similar to the other types of pulmonary hypertension (ph) that tend to reduce blood flow along with increasing the pressure in one's blood vessels that are present in the body. Thus chronic is defined as a long-lasting illness; thromboembolic is a complete or partial blockage of one's blood vessel because of a blood clot that may have broken during formation. In case, you are suffering from this condition then make sure that without wasting time you MUST get yourself treated at the earliest. Here, are the symptoms, causes and risk factors of this condition.
Also Read: Alcohol Gastritis: Causes, Symptoms, Treatments and More
These are the causes of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)One may suffer from Chronic Thromboembolic Pulmonary Hypertension owing to the blood clots present in the lungs resulting in scarring that may block arteries in the lungs. Few conditions like blood diseases or inflammatory diseases can raise one's risk of CTEPH. The potential causes can be not having a spleen, unprovoked large pulmonary embolisms, blood clotting disorders like lupus or ones with infected a pacemaker can also suffer from this condition.
If you exhibit symptoms like feeling weak or tired on the daily basis, tend to experience breathing difficulties especially while you are exercising, chest pain or pounding in the chest, leg swelling because of fluid retention or fainting then just visit your expert who will initiate appropriate treatment.
Also Read: Probiotic Foods for Acne: Know 5 foods which may help
Are you aware of these risk factors of Chronic Thromboembolic Pulmonary HypertensionAnyone irrespective of their age can suffer from Chronic Thromboembolic Pulmonary Hypertension. Did you know? Even if Chronic Thromboembolic Pulmonary Hypertension may tend to develop from pulmonary embolisms (that is known as the blood clots in the lungs), A large number of people with Chronic Thromboembolic Pulmonary Hypertension may not have had PEs earlier. It is no brainer that ageing can be one of the culprits but along with it being inactive for a longer period, being obese, smoking and suffering from certain diseases like cancer can also be blamed for.
Patients with CTEPH can be treated with the help of pulmonary thromboendarterectomy also known as PTE that can help one deal with the disease and reduce the symptoms. This open-chest surgery can allow the removal of scar tissue and clots from the patient's pulmonary arteries. Likewise, one will also be able to get rid of blockages in the blood vessels and enhance the functioning of the lungs by restoring the normal circulation. But, you MUST also keep in mind that not everyone is a suitable candidate for PTE. Some people can also be cured with medications. Hence, the treatment may vary from person to person.
(With inputs from Dr Bipeenchandra Bhamre, Cardio-Thoracic Surgeon, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai)
Read more articles on Other Diseases
DisclaimerAll possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however Onlymyhealth.Com does not take any liability for the same. Using any information provided by the website is solely at the viewers' discretion. In case of any medical exigencies/ persistent health issues, we advise you to seek a qualified medical practitioner before putting to use any advice/tips given by our team or any third party in form of answers/comments on the above mentioned website.
Comments
Post a Comment